{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:01:11Z","timestamp":1715594471878},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1093\/ndt\/gfp407","type":"journal-article","created":{"date-parts":[[2009,8,8]],"date-time":"2009-08-08T00:26:17Z","timestamp":1249691177000},"page":"3651-3658","source":"Crossref","is-referenced-by-count":11,"title":["Azelnidipine exerts renoprotective effects by improvement of renal microcirculation in angiotensin II infusion rats"],"prefix":"10.1093","volume":"24","author":[{"given":"Sohachi","family":"Fujimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Nagasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Horike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamaki","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kashihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,8,7]]},"reference":[{"key":"key\n\t\t\t\t20170515165618_R1","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJM198806233182505","article-title":"The progression of renal disease","volume":"318","author":"Klahr","year":"1988","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515165618_R2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(12)80312-X","article-title":"Tubulointerstitial changes as a major determinant in the progression of renal damage","volume":"20","author":"Nath","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170515165618_R3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000174072","article-title":"Significance of postglomerular capillaries in the pathogenesis of chronic renal failure","volume":"19","author":"Bohle","year":"1996","journal-title":"Kidney Blood Press Res"},{"key":"key\n\t\t\t\t20170515165618_R4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1681\/ASN.V11147","article-title":"Peritubular capillary injury during the progression of experimental glomerulonephritis in rats","volume":"11","author":"Ohashi","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515165618_R5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1681\/ASN.2005070757","article-title":"Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure","volume":"17","author":"Nangaku","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515165618_R6","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/ki.1993.114","article-title":"Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms","volume":"43","author":"Dworkin","year":"1993","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515165618_R7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/01.HYP.20.2.233","article-title":"Adverse effect of the calcium channel blocker nitrendipine on nephrosclerosis in rats with renovascular hypertension","volume":"20","author":"Wenzel","year":"1992","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170515165618_R8","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1523-1755.2004.00859.x","article-title":"Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes","volume":"66","author":"Ma","year":"2004","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20170515165618_R9","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/01.ASN.0000093242.48333.3B","article-title":"Guidelines for antihypertensive treatment: an update after the ALLHAT study","volume":"15","author":"Salvetti","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515165618_R10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0140-6736(00)02527-7","article-title":"Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)","volume":"356","author":"Brown","year":"2000","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170515165618_R11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005344-198301000-00010","article-title":"Clinical effects of intravenous nifedipine on renal function","volume":"5","author":"Yokoyama","year":"1983","journal-title":"J Cardiovasc Pharmacol"},{"key":"key\n\t\t\t\t20170515165618_R12","first-page":"329","article-title":"Effects of verapamil and nifedipine on renal function and hemodynamics in the dog","volume":"7","author":"Bell","year":"1984","journal-title":"Ren Physiol"},{"key":"key\n\t\t\t\t20170515165618_R13","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515165618_R14","first-page":"F1015","article-title":"Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG II","volume":"256","author":"Carmines","year":"1989","journal-title":"Am J Physiol"},{"key":"key\n\t\t\t\t20170515165618_R15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1042\/cs1010421","article-title":"Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis","volume":"101","author":"Honda","year":"2001","journal-title":"Clin Sci (Lond)"},{"key":"key\n\t\t\t\t20170515165618_R16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1254\/jphs.FP0061139","article-title":"The long-acting Ca2+-channel blocker azelnidipine prevents left ventricular remodeling after myocardial infarction","volume":"103","author":"Nishiya","year":"2007","journal-title":"J Pharmacol Sci"},{"key":"key\n\t\t\t\t20170515165618_R17","first-page":"637","article-title":"Effects of CS-905, a novel dihydropyridine calcium channel blocker, on arterial pressure, renal excretory function, and inner medullary blood flow in the rat","volume":"7","author":"Yagil","year":"1994","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t20170515165618_R18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1291\/hypres.25.447","article-title":"Combination therapy with an angiotensin-converting enzyme (ACE) inhibitor and a calcium antagonist: beyond the renoprotective effects of ACE inhibitor monotherapy in a spontaneous hypertensive rat with renal ablation","volume":"25","author":"Kanazawa","year":"2002","journal-title":"Hypertens Res"},{"key":"key\n\t\t\t\t20170515165618_R19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/MAJ.0b013e318065c254","article-title":"Azelnidipine reduces urinary protein excretion and urinary liver-type fatty acid binding protein in patients with hypertensive chronic kidney disease","volume":"333","author":"Nakamura","year":"2007","journal-title":"Am J Med Sci"},{"key":"key\n\t\t\t\t20170515165618_R20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1523-1755.2001.00808.x","article-title":"In vivo visualization of angiotensin II- and tubuloglomerular feedback-mediated renal vasoconstriction","volume":"60","author":"Yamamoto","year":"2001","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515165618_R21","doi-asserted-by":"crossref","first-page":"F1150","DOI":"10.1152\/ajprenal.00310.2001","article-title":"Intravital videomicroscopy of peritubular capillaries in renal ischemia","volume":"282","author":"Yamamoto","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"key\n\t\t\t\t20170515165618_R22","doi-asserted-by":"crossref","first-page":"F571","DOI":"10.1152\/ajprenal.2001.281.3.F571","article-title":"In vivo visualization of characteristics of renal microcirculation in hypertensive and diabetic rats","volume":"281","author":"Yamamoto","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"key\n\t\t\t\t20170515165618_R23","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1291\/hypres.28.1017","article-title":"Effects of a new calcium channel blocker, azelnidipine, on systemic hemodynamics and renal sympathetic nerve activity in spontaneously hypertensive rats","volume":"28","author":"Shokoji","year":"2005","journal-title":"Hypertens Res"},{"key":"key\n\t\t\t\t20170515165618_R24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jjp.54.1","article-title":"Hemodynamic changes following long-term administration of CS-905, a novel dihydropyridine calcium blocker, in conscious SHR","volume":"54","author":"Oizumi","year":"1990","journal-title":"Jpn J Pharmacol"},{"key":"key\n\t\t\t\t20170515165618_R25","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.amjhyper.2007.05.007","article-title":"Olmesartan ameliorates renovascular injury and oxidative stress in Zucker obese rats enhanced by dietary protein","volume":"20","author":"Namikoshi","year":"2007","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t20170515165618_R26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/01.HYP.19.5.464","article-title":"Renal injury from angiotensin II-mediated hypertension","volume":"19","author":"Johnson","year":"1992","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170515165618_R27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ki.1994.67","article-title":"Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis","volume":"45","author":"Giachelli","year":"1994","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515165618_R28","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1254\/jjp.51.501","article-title":"Beneficial renal effects of CS-905, a novel dihydropyridine calcium blocker, in SHR","volume":"51","author":"Oizumi","year":"1989","journal-title":"Jpn J Pharmacol"},{"key":"key\n\t\t\t\t20170515165618_R29","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/01.RES.0000256155.31133.49","article-title":"Ca2+ channel subtypes and pharmacology in the kidney","volume":"100","author":"Hayashi","year":"2007","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20170515165618_R30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000072054","article-title":"Role of actions of calcium antagonists on efferent arterioles\u2014with special references to glomerular hypertension","volume":"23","author":"Hayashi","year":"2003","journal-title":"Am J Nephrol"},{"key":"key\n\t\t\t\t20170515165618_R31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1291\/hypres.30.359","article-title":"Azelnidipine attenuates cardiovascular and sympathetic responses to air-jet stress in genetically hypertensive rats","volume":"30","author":"Nakamoto","year":"2007","journal-title":"Hypertens Res"},{"key":"key\n\t\t\t\t20170515165618_R32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1681\/ASN.V13127","article-title":"Preglomerular and postglomerular resistance responses to different levels of sympathetic activation by hypoxia","volume":"13","author":"Denton","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515165618_R33","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1124\/jpet.105.095331","article-title":"Effects of calcium channel blockade on angiotensin II-induced peritubular ischemia in rats","volume":"316","author":"Kondo","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170515165618_R34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/FJC.0b013e31819f1be1","article-title":"Chronotropic effects of azelnidipine, a slow- and long-acting dihydropyridine-type calcium channel blocker, in anesthetized dogs: a comparison with amlodipine","volume":"53","author":"Fujisawa","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"key":"key\n\t\t\t\t20170515165618_R35","first-page":"F84","article-title":"Morphological heterogeneity of renal glomerular arterioles and distinct [Ca2+]i responses to ANG II","volume":"273","author":"Helou","year":"1997","journal-title":"Am J Physiol"},{"key":"key\n\t\t\t\t20170515165618_R36","doi-asserted-by":"crossref","first-page":"F507","DOI":"10.1152\/ajprenal.00430.2002","article-title":"Angiotensin receptor subtypes in thin and muscular juxtamedullary efferent arterioles of rat kidney","volume":"285","author":"Helou","year":"2003","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/24\/12\/3651\/17107515\/gfp407.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T13:27:44Z","timestamp":1633786064000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article-lookup\/doi\/10.1093\/ndt\/gfp407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,7]]},"references-count":36,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2009,8,7]]},"published-print":{"date-parts":[[2009,12]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfp407","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8,7]]}}}